Get the Stockscreener App
34.98
2.67%
-0.76
Medline Inc stock is traded at $34.98, with a volume of 2.47M.
It is down -2.67% in the last 24 hours and down -12.57% over the past month.
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
See More
Previous Close:
$35.74
Open:
$35.27
24h Volume:
2.47M
Relative Volume:
0.26
Market Cap:
$30.65B
Revenue:
$29.14B
Net Income/Loss:
$1.07B
P/E Ratio:
29.26
EPS:
1.1956
Net Cash Flow:
$1.05B
1W Performance:
+2.89%
1M Performance:
-12.57%
6M Performance:
-24.64%
1Y Performance:
+0.00%
1-Day Range:
$34.56
$35.63
1-Week Range:
$33.10
$36.23
52-Week Range:
$32.81
$50.88
Medline Inc Stock (MDLN) Company Profile
Name
Medline Inc
Sector
Industry
Phone
847-949-3000
Address
3 LAKES DRIVE, NORTHFIELD
Compare MDLN vs ISRG, BDX, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDLN
Medline Inc
|
34.94 | 31.36B | 29.14B | 1.07B | 1.05B | 1.1956 |
ISRG
Intuitive Surgical Inc
|
391.06 | 139.37B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
182.40 | 49.96B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
72.70 | 35.89B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
220.40 | 32.38B | 5.54B | 1.52B | 1.74B | 10.37 |
Medline Inc Stock (MDLN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-11-26 | Resumed | Citigroup | Buy |
| Feb-05-26 | Initiated | Tigress Financial | Buy |
| Jan-21-26 | Reiterated | BTIG Research | Buy |
| Jan-12-26 | Initiated | Citigroup | Buy |
| Jan-12-26 | Initiated | Deutsche Bank | Hold |
| Jan-12-26 | Initiated | Evercore ISI | Outperform |
| Jan-12-26 | Initiated | Goldman | Buy |
| Jan-12-26 | Initiated | JP Morgan | Overweight |
| Jan-12-26 | Initiated | Jefferies | Buy |
| Jan-12-26 | Initiated | Leerink Partners | Outperform |
| Jan-12-26 | Initiated | Mizuho | Outperform |
| Jan-12-26 | Initiated | Morgan Stanley | Overweight |
| Jan-12-26 | Initiated | Piper Sandler | Overweight |
| Jan-12-26 | Initiated | RBC Capital Mkts | Outperform |
| Jan-12-26 | Initiated | Robert W. Baird | Outperform |
| Jan-12-26 | Initiated | Rothschild & Co Redburn | Neutral |
| Jan-12-26 | Initiated | Stifel | Buy |
| Jan-12-26 | Initiated | TD Cowen | Buy |
| Jan-12-26 | Initiated | Truist | Buy |
| Jan-12-26 | Initiated | UBS | Buy |
| Jan-12-26 | Initiated | Wells Fargo | Equal Weight |
| Jan-12-26 | Initiated | William Blair | Outperform |
| Jan-12-26 | Initiated | Wolfe Research | Outperform |
View All
Medline Inc Stock (MDLN) Latest News
Medline Inc. (MDLN) Stock Plummets 7% Amid FDA Warning Letter and Securities Law Probe - Kalkine Media
Kaplan Fox Notifies Investors of Medline Inc. (NASDAQ: MDLN) of a - The National Law Review
Medline Inc. (MDLN) Shares Drop 7% After FDA Warning Letter Triggers Securities Law Investigation - kalkine.ca
Tigress Financial Adjusts Medline Price Target to $55 From $62, Maintains Buy Rating - marketscreener.com
Kaplan Fox Encourages Investors of Medline Inc. (NASDAQ: MDLN) to - The National Law Review
MDLN News Today | Why did Medline stock go up today? - MarketBeat
Medline stock drops over 7% after FDA cites maj... - Pluang
MDLN Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm - Morgan County Citizen
Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Potential Securities Law ViolationsInvestors are Encouraged to Contact the Firm - The Globe and Mail
Medline Convenience Kits Impacted By Contamination In Recalled Becton Dickinson Products - Benzinga
Medline Inc. Class A Common Stock (NASDAQ: MDLN) Stock Price, News & Analysis - Kalkine
Medline faces securities probe after FDA cites manufacturing violations, stock drops 7%. - Pluang
Kaplan Fox Investigates Medline Inc. Over Alleged Securities Violations Following FDA Warning Letters - kalkine.ca
GIC Private Ltd sells $21m Medline Inc. (MDLN) shares By Investing.com - Investing.com UK
Hellman & Friedman funds (MDLN) report 153M Medline Class A shares in latest ownership update - Stock Titan
Tigress Financial lowers Medline stock price target on fire impact By Investing.com - Investing.com UK
Private Ltd Gic Sells 590,284 Shares of Medline (NASDAQ:MDLN) Stock - MarketBeat
Tigress Financial lowers Medline stock price target on fire impact - Investing.com
GIC Private Ltd sells $21m Medline Inc. (MDLN) shares - Investing.com
Wells Fargo & Company Cuts Medline (NASDAQ:MDLN) Price Target to $34.00 - MarketBeat
MEDLINE INC. : TD COWEN CUTS TARGET PRICE TO $45 FROM $53 - Bitget
Medline $MDLN Shares Acquired by Cetera Investment Advisers - MarketBeat
Bank of America Corp DE Lowers Holdings in Medline $MDLN - MarketBeat
Blackstone entities (NASDAQ: MDLN) report 153.3M Medline shares, 16.5% stake - Stock Titan
Medline stock drops over 19% after FDA cites ma... - Pluang
NASDAQ: MDLN Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm - PR Newswire
Medline Inc. (MDLN) major holder sells 2,248,612 shares, keeps large stake - Stock Titan
Kaplan Fox Notifies Investors of Medline Inc. (NASDAQ: MDLN) of an Investigation Into Potential Securities Law Violations - barchart.com
Medline Q2 2026 EPS Tops Expectations by 56.2%, Revenue Up 12% - AlphaStreet
FMR LLC discloses 5.5% Medline Inc (MDLN) Class A ownership stake - Stock Titan
Medline Inc. Stock 12‑Month Price Target Cut to $46.69, Implies 27% Upside - TradingView
MEDLINE INC. : BMO CUTS TARGET PRICE TO $47 FROM $54 - Bitget
MEDLINE INC. : CITIGROUP CUTS TARGET PRICE TO $45 FROM $55 - Bitget
Medline Earnings: Solid Sales Momentum Overshadowed by Margin Concerns, but Selloff Overblown - Morningstar
Medline Inc. Q2 2026: Revenue $7.685B, EPS $0.07— 10-Q Summary - TradingView
Medline shares tumble after warehouse fire tanks profit - Crain's Chicago Business
MEDLINE INC Q2 NET INCOME USD 139 MILLION - Moomoo
Earnings call transcript: Medline Industries Q2 2026 results spark 14.8% drop - Investing.com
Medline Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:MDLN) 2026-08-05 - Seeking Alpha
Medline Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Here's What Key Metrics Tell Us About Medline (MDLN) Q2 Earnings - Yahoo Finance
Medline Inc. (MDLN) Q2 FY2026 earnings call transcript - Yahoo Finance
Earnings Flash (MDLN) Medline Inc. Posts Q2 Adjusted EPS $0.50 per Share, vs. FactSet Est of $0.32 - marketscreener.com
Medline posts Q2 sales $7.7B, Adjusted EBITDA $1.06B; updates 2026 organic sales and EBITDA outlook - TradingView
Medline Reports Second Quarter 2026 Results, Raises Full-Year Organic Sales Guidance and Updates Adjusted EBITDA Outlook - Quiver Quantitative
Medline: Q2 Earnings Snapshot - Barchart.com
Fire loss hits Medline Inc. (Nasdaq: MDLN) profit despite 11.6% sales growth - Stock Titan
MEDLINE INC Q2 PRETAX PROFIT USD 235 MILLION - Moomoo
Medline Reports Second Quarter and First Six Months 2026 Results - Yahoo Finance
497,793,652 Class A Common Stock of Medline Inc. are subject to a Lock-Up Agreement Ending on 5-AUG-2026. - marketscreener.com
Medline Inc Stock (MDLN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Medline Inc Stock (MDLN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| GIC Private Ltd | 10% Owner |
Aug 05 '26 |
Sale |
35.60 |
1,976,618 |
70,361,900 |
25,264,760 |
| GIC Private Ltd | 10% Owner |
Aug 06 '26 |
Sale |
35.33 |
271,994 |
9,609,548 |
24,992,766 |
| Golwas Douglas P | Chief Commercial Officer |
Jun 16 '26 |
Sale |
36.77 |
100,000 |
3,677,115 |
23,899 |
1.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):